logo
Jarden Sticks to Its Buy Rating for Telstra Corporation Limited (TTRAF)

Jarden Sticks to Its Buy Rating for Telstra Corporation Limited (TTRAF)

Jarden analyst Tom Beadle maintained a Buy rating on Telstra Corporation Limited (TTRAF – Research Report) on May 28 and set a price target of A$4.70. The company's shares closed last Wednesday at $3.00.
Confident Investing Starts Here:
Beadle covers the Communication Services sector, focusing on stocks such as TPG Telecom Limited, Telstra Corporation Limited, and Seek Limited. According to TipRanks, Beadle has an average return of -0.7% and a 55.41% success rate on recommended stocks.
In addition to Jarden, Telstra Corporation Limited also received a Buy from Morgan Stanley's Andrew McLeod in a report issued on May 28. However, on the same day, UBS downgraded Telstra Corporation Limited (Other OTC: TTRAF) to a Hold.
TTRAF market cap is currently $34.81B and has a P/E ratio of 29.11.
Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TTRAF in relation to earlier this year.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Top analyst resets Nvidia price target for one surprising reason before earnings
Top analyst resets Nvidia price target for one surprising reason before earnings

Miami Herald

time2 hours ago

  • Miami Herald

Top analyst resets Nvidia price target for one surprising reason before earnings

Nvidia (NVDA) stock just got a major price target reset ahead of earnings, but the twist isn't more AI hype. KeyBanc Capital Markets John Vinh's call is built around a factor effectively hiding in plain sight, something investors haven't fully priced in. It's not about demand, nor is it about China, or even the usual AI narrative. Don't miss the move: Subscribe to TheStreet's free daily newsletter Instead, it's a potential shift that could change how quickly Nvidia is able to ramp up sales, while fattening up its margins in the process. Moreover, with expectations sky-high already, this quiet revamp could be an overlooked driver, making Nvidia's Q2 earnings print one to watch more closely. John Vinh, managing director and equity research analyst at KeyBanc Capital Markets, has a keen eye on the chip space and AI-infrastructure supply chains. Among the stocks he covers closely is Nvidia, along with other chip names, and he has become a trusted voice on the sector. On TipRanks, he attracts a 5-star rating, with an impressive 60% success rate and an 18.9% average return per rating. This makes him one of the top-ranked tech analysts tracked on the platform. For perspective, Dan Ives of Wedbush fame has just a 49% success rate on the platform. Ahead of Nvidia's Q2 earnings report on August 27, KeyBanc's John Vinh lifted his Nvidia price target to $215 from $190, on the back of better manufacturing yields. Specifically, Vinh cites the GB200 server rack yields nearing an incredible 85%, which means that more systems are breezing through QA and shipping faster. Related: Cathie Wood drops $21.6 million on biotech stock That improved throughput has him raising his full-year rack shipment forecast to 30,000 units, up from 25,000. Simply put, Nvidia's backlog is being converted into sales at a much quicker pace, on the back of more efficient execution at the factory level. Supply is catching up, too. Blackwell B200 availability has surged at an eye-catching 40% in Q2, and it's set to climb another 20% in Q3. The rollout of Blackwell Ultra is also accelerating, potentially making up 50% of Blackwell shipments by October, resulting in a more diverse product mix. On numbers, Vinh now sees Q2 sales at $47.1 billion (consensus estimate at $45.7 billion) but trims Q3 to $50.4 billion (consensus estimate at $53.5 billion), excluding China due to license uncertainty. If we include China, he sees even greater upside of $2 billion to $3 billion, driven by H20 and RTX6000D (B40) shipments. Nvidia dominates the AI hardware stack with a whopping 80% market share, covering chips, systems, networking, and sticky CUDA software. That grip naturally shows up in its financials. Nvidia posted $130.5 billion in FY2025 sales, more than 50% from last year, with U.S. hyperscalers deploying millions of accelerators in training and running their AI models. Blackwell is a big part of that impressive lead. Nvidia's new Blackwell B200/GB200 platform is a beast, packing 208 billion transistors, a fresh Transformer Engine, and NVLink "super-highways" that let 576 GPUs act like one giant brain. Related: Top tech stock analyst revamps AI 'buy' list The result is that it efficiently delivers 30-times quicker inference and much speedier AI responses, like almost instantaneous chatbot replies. Memory is another massive leap. Blackwell uses HBM3e (High Bandwidth Memory 3e special stacked DRAM right next to a potent processor for ultra-fast data access), handling up to 288GB per GPU. Analysts feel Blackwell could contribute 80% of Nvidia's high-end shipments in 2025, while Nvidia is set to control north of 70% of HBM supply. Nvidia is set to report its fiscal year 2026 Q2 results Aug. 27, and here's what Wall Street expects: Revenue: $45.7 billion to $45.9 billion (management guided for around $45 billion in sales)EPS: Roughly $1Gross margin: 71.8% (marker); 5-year average is 66.2%. The big swing factors? The first is Data Center momentum, which has been massive over the past several quarters, particularly at $39.1 billion in Q1. Second, there's the early Blackwell ramp with more B200 chips flowing in and GB200 racks passing quality checks a lot quicker, pulling revenue forward. Related: Billionaire fund manager doubles down on Nvidia, partner in AI stack shift Finally, there's the plumbing, where networking gear like NVLink switches and full racks are moving abroad with memory (HBM) and packaging bottlenecks. Wall Street models expect Nvidia to beat Q2 numbers, where some see Q2 revenue hitting closer to $47 billion, but Q3 staying near $50 billion to $52 billion, depending on geopolitics. Investors shouldn't expect a clean boost from China in Nvidia's guidance just yet. The U.S. only started issuing H20 licenses on August 8, and reports surfaced from Beijing, where it discouraged its use for sensitive work. Meanwhile, Nvidia is cooking up a more robust Blackwell-based "B30A," but still needs customer testing and volume. More News: Billionaire George Soros supercharges Nvidia stake, loads up on AI playsTesla just got its biggest break yet in the robotaxi wars with a key permitBank of America drops shocking price target on hot weight-loss stock post-earnings On top of that, Washington is weighing a 15% revenue-share tax on China's AI-chip sales from Nvidia and AMD. According to White House press secretary Karoline Leavitt, despite the hurdles, the Commerce Department is still focused on getting the deal done. Related: Legendary fund manager Stanley Druckenmiller buys $133 million of under-radar AI stock The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk
U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk

Business Insider

time2 hours ago

  • Business Insider

U.S. Tariffs on India Could Backfire, Putting Apple (AAPL) and Tech Giants at Risk

Columbia University economist Jeffrey Sachs has warned that recent U.S. tariffs on India could backfire. Speaking on the Breaking Points show, Sachs said the move has pushed India closer to China and helped strengthen BRICS (Brazil, Russia, India, China, and South Africa) against American interests. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Sachs called the tariffs 'the stupidest tactical move in US foreign policy' and argued they were more about politics than strategy. He singled out South Carolina Senator Lindsey Graham for criticism, describing him as a poor voice on trade. Sachs also dismissed former Trump trade adviser Peter Navarro as unqualified, despite his Harvard degree. Impact on BRICS Unity The tariffs include a 25% penalty on Indian purchases of Russian oil. According to Sachs, the measure had the opposite of its intended effect. Rather than isolating Russia, it brought BRICS members into closer coordination. He noted that within two days of the announcement, leaders from BRICS countries were on calls working more closely together. China, which buys more Russian oil than India, was not targeted by similar tariffs. This uneven approach drew criticism from former U.S. officials as well. John Bolton, who served as Trump's National Security Adviser, called the move a mistake that weakened trust with India. Tariffs Put Trade, Tech, and Defense at Risk Beyond trade, Sachs warned of long-term damage to relations. The U.S. has spent years building ties with India as part of its Asia strategy. However, he argued the tariffs risk undoing that progress. Sachs said India now views the U.S. as unreliable, regardless of whether the penalties are lifted. If U.S.-India ties continue to weaken, the impact could spread across industries on both sides. Apple (AAPL) may face higher costs for its India-based manufacturing, while Microsoft (MSFT), Google (GOOG), and Amazon (AMZN) could see pressure on their Indian hubs that rely on local talent. Also at risk are Indian exporters in textiles, gems, jewelry, auto parts, and foodstuffs face tariffs on goods worth $48.2 billion. At the same time, defense and technology cooperation between firms such as Lockheed Martin (LMT), Boeing (BA), and Indian defense groups could lose momentum if trust erodes. These risks threaten supply chains, exports, and investment across the $200 billion trade relationship. The warning comes as US policy focuses on countering China's influence in Asia. If ties with India continue to sour, analysts suggest Washington may face a key question: who lost India? Using TipRanks' Comparison Tool, we've brought together all the stocks mentioned in this piece, giving investors a clear view of how each company stacks up and how the industries compare overall.

BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer
BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

Yahoo

time4 hours ago

  • Yahoo

BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

POMPANO BEACH, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, discloses an insider purchase of common stock from Jason Matuszewski, Chairman and Chief Executive Officer of BioStem Technologies. Mr. Matuszewski purchased a total of 15,500 shares on August 19, 2025, totaling approximately $100,000. The purchases were made through two separate transactions: 2,500 shares at an average price of $6.28 and 13,000 shares at an average price of $6.51. Following these transactions, Mr. Matuszewski owns 1,145,362 shares of BioStem Technologies stock. For more information about the purchases, please visit the OTCID disclosure website HERE under Officer/Director/Affiliate Stock Transactions. About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ('AATB'). These systems and procedures are established per current Good Tissue Practices ('cGTP') and current Good Manufacturing Processes ('cGMP'). Our portfolio of quality brands includes AmnioWrap2™, VENDAJE®, VENDAJE AC®, and VENDAJE OPTIC®. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida. For more information visit and follow us on X and LinkedIn. Join BioStem's Distribution List & Social Media:To follow the latest developments at BioStem, sign-up to the Company's email distribution list HERE, and follow us on X and LinkedIn. Contact BioStem Technologies, Inc.:Website: info@ @BSEM_TechFacebook: BioStemTechnologiesPhone: 954-380-8342 Investor Relations:Adam Holdsworth, BioStem Director of Investor RelationsE-Mail: adam@ Phone: 917-497-9287 Or Gilmartin GroupPhilip Trip Taylor, Principal E-Mail: philip@ Phone: 415-937-5406Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store